🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06835179
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
This study is a prospective, randomized, single-center randomized controlle...
Status
Recruiting
Location
First Affiliated Hospital of Wenzhou Medical University
Start Date
2026-04-30
Trial ID
NCT07381634
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and tolerability ...
Status
Recruiting
Location
Liverpool Cancer Therapy Centre
Start Date
2025-11
Trial ID
NCT07244705
Treatments Being Tested
This study will look at whether adding daily oral zinc supplements to targe...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Start Date
2026-09-01
Trial ID
NCT07793695
This is a single-arm interventional study targeting patients with initially...
Status
Active Not Recruiting
Location
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Start Date
2026-02-26
Trial ID
NCT07512674
Combination treatment with antiangiogenic agents and anti-programmed cell d...
Status
Unknown
Location
Zhongshan Hospital, Fudan University
Start Date
2020-12-23
Trial ID
NCT04639284
Treatments Being Tested
To evaluate the clinical efficacy and safety of TAS-102 combined with bevac...
Status
Unknown
Location
FujianCH
Start Date
2022-04-01
Trial ID
NCT05314101
Treatments Being Tested
This multicenter, prospective, randomized, controlled, open-label, two-arm ...
Status
Recruiting
Location
Jinan, Shandong 0531
Start Date
2025-07-21
Trial ID
NCT06841172
To investigate the efficacy, safety and tolerability of superselective cere...
Status
Unknown
Location
Multiple Locations
Start Date
2023-04-15
Trial ID
NCT05811793
Treatments Being Tested